Recognized as a “Rising Star” in antitrust litigation, Abram Ellis is a Partner in the Firm’s Washington, D.C. office. His practice comprises all aspects of competition law, from defending clients against complex class action antitrust litigation to helping clients obtain regulatory clearance from domestic and international competition authorities for significant transactions. An integral member of the “Antitrust Team of the Year” (Chambers USA 2016), Abram is particularly experienced in antitrust litigation involving complex financial instruments. He has also represented numerous healthcare clients in antitrust class actions and related government investigations.
In addition to his robust litigation practice, Abram advises leading private equity funds, financial institutions and major corporations on the regulatory matters relating to cross-border activities, including on OFAC and FCPA matters.
Read Full Biography...
- Tradeweb in antitrust class actions involving interest rate swaps.
- ISDA in antitrust class actions and government investigations concerning credit default swaps.
- HCA Inc. in antitrust actions involving ambulatory surgery centers and certain compensation matters.
- JPMorgan in antitrust and CEA class actions concerning the alleged manipulation of LIBOR.
- Sandoz, a generic pharmaceuticals company, in an FTC investigation and follow-on private litigation concerning an alleged “pay-for-delay” agreement.
- Blackstone in antitrust class actions involving alleged collusion for leveraged-buyout transactions.
2014-2015 Super Lawyers "Rising Star" for Antitrust Litigation
University of Michigan Law School, 2005 J.D.
Johns Hopkins School of Advanced International Studies, 2002 M.A.
John C. Foster Award, SAIS Review Book Review Editor
Brigham Young University, 2000 B.A.
- New York State Bar Association
District of Columbia 2006
New York 2006
U.S. Court of Appeals for the Second Circuit 2017
Based in the Washington, D.C. office, Abram Ellis is a Partner whose practice focuses on antitrust matters – including class action litigation, antitrust merger review and antitrust counselling – and on regulatory issues present in international and cross-border transactions.
Abram regularly represents clients in some of the most high-profile, pending private antitrust actions. He has also successfully helped clients navigate the antitrust merger review process, and regularly consults and advises clients on potential business activities and strategies, new industry developments, and contracting activities. For both 2014 and 2015, Abram was recognized by Super Lawyers as a “Rising Star” for Antitrust Litigation.
Abram also has substantial experience advising clients regarding U.S. laws relevant to international and cross-border transactions, including advising clients on matters involving regulations administered by the U.S. Treasury Department’s Office of Foreign Assets Control and the U.S. Commerce Department’s Bureau of Industry and Security, U.S. economic sanctions laws targeting Iran, and the Foreign Corrupt Practices Act.
He graduated from the University of Michigan Law School in 2005, cum laude, after obtaining an M.A. in International Relations from the Johns Hopkins University School of Advanced International Studies and a B.A. from Brigham Young University.